Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-da0ff5a082bee96e: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-81b68fca2fa0a772: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-bf79b277e030fdf9: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-2c9ba5f95ada7224: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-1bb44b2472cf7fb5: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-cae47120261597a8: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-fce39b8ce8bea39f: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-91bc868a4978be1a: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-740cc59df335a86f: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-a92b6b3bdcb41c02: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-da0ff5a082bee96e
- pantheon_debate:pd-81b68fca2fa0a772
- pantheon_debate:pd-bf79b277e030fdf9
- pantheon_debate:pd-2c9ba5f95ada7224
- pantheon_debate:pd-1bb44b2472cf7fb5
- pantheon_debate:pd-cae47120261597a8
- pantheon_debate:pd-fce39b8ce8bea39f
- pantheon_debate:pd-91bc868a4978be1a
- pantheon_debate:pd-740cc59df335a86f
- pantheon_debate:pd-a92b6b3bdcb41c02
Context
{"topic":"general","source_refs":["pantheon_debate:pd-da0ff5a082bee96e","pantheon_debate:pd-81b68fca2fa0a772","pantheon_debate:pd-bf79b277e030fdf9","pantheon_debate:pd-2c9ba5f95ada7224","pantheon_debate:pd-1bb44b2472cf7fb5","pantheon_debate:pd-cae47120261597a8","pantheon_debate:pd-fce39b8ce8bea39f","pantheon_debate:pd-91bc868a4978be1a","pantheon_debate:pd-740cc59df335a86f","pantheon_debate:pd-a92b6b3bdcb41c02"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10